Latest round: IPO. Andrea Pfeifer co-founded AC Immune SA in 2003, a Swiss clinical-stage biopharma company focused on precision medicine.
Dr. Andrea Pfeifer co-founded AC Immune SA in 2003, a Swiss clinical-stage biopharma company focused on precision medicine for neurodegenerative diseases. She served as CEO from the company's founding until its IPO in 2016, and continues as the Chief Executive Officer of AC Immune.
Full founder directory · Investor directory · Company funding database · Fundraising library